Ryosuke Satomi
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Medical Imaging and Pathology Studies 2
- Lung Cancer Diagnosis and Treatment 2
-
- RNA modifications and cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Katsuhiko Naoki (11 shared papers)Kenzo Soejima (11 shared papers)Shinnosuke Ikemura (9 shared papers)Takashi Sato (10 shared papers)Satoshi Yoda (10 shared papers)Sohei Nakayama (10 shared papers)Hideki Terai (10 shared papers)Tomoko Betsuyaku (6 shared papers)
- Journals
- Molecular Cancer Research (2 papers)Lung Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Clinical Lung Cancer (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Ryosuke Satomi
17 papers receiving 552 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 192
- Pulmonary and Respiratory Medicine 259
- Oncology 206
- Molecular Biology 323
- Immunology 41
Countries citing papers authored by Ryosuke Satomi
This map shows the geographic impact of Ryosuke Satomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Satomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Satomi more than expected).
Fields of papers citing papers by Ryosuke Satomi
This network shows the impact of papers produced by Ryosuke Satomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Satomi. The network helps show where Ryosuke Satomi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Satomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 174 | |
| 2 | 2022 | 61 | |
| 3 | 2013 | 54 | |
| 4 | 2018 | 45 | |
| 5 | 2011 | 39 | |
| 6 | 2014 | 38 | |
| 7 | FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. | 2015 | 35 |
| 8 | 2010 | 24 | |
| 9 | 2010 | 17 | |
| 10 | 2013 | 17 | |
| 11 | 2014 | 17 | |
| 12 | 2016 | 15 | |
| 13 | 2023 | 11 | |
| 14 | 2010 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2021 | 1 | |
| 17 | 2019 | 1 |
About Ryosuke Satomi
Ryosuke Satomi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Epidemiology, having authored 17 papers that have together received 556 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), MicroRNA in disease regulation (2 papers), Medical Imaging and Pathology Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (192 citations), Pulmonary and Respiratory Medicine (259 citations), Oncology (206 citations), Molecular Biology (323 citations) and Immunology (41 citations). Ryosuke Satomi has collaborated with scholars based in Japan and United States. Frequent co-authors include Katsuhiko Naoki, Kenzo Soejima, Shinnosuke Ikemura, Takashi Sato, Satoshi Yoda, Sohei Nakayama, Hideki Terai, Tomoko Betsuyaku, Hiroyuki Yasuda and Junko Hamamoto. Their work appears in journals such as Molecular Cancer Research, Lung Cancer, Cancer Chemotherapy and Pharmacology, Clinical Lung Cancer and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.